Remedee Labs News
Remedee Labs strengthens its Board of Directors and Advisory Board with the arrival of Florence DUPRÉ and Julie FOSTER
Remedee Labs, a French start-up that specializes in non-pharmaceutical chronic pain management and just announced the positive results of its clinical study on osteoarthritis is
Remedee Labs announces positive results from its clinical trial on osteoarthritis.
Remedee Labs, a French startup that specializes in non-pharmaceutical treatments for chronic pain, is announcing the highly anticipated results of its clinical study assessing the
UPSA and the startup Remedee Labs announce a partnership to improve the quality of life and well-being of patients living with chronic pain
February 1st, 2023 – Today, the French pharmaceutical company UPSA and the startup Remedee Labs are announcing the signature of a partnership to offer healthcare
Remedee Labs is raising €12.2 million.
Remedee Labs, a French start-up that specializes in non-pharmaceutical treatments for chronic pain, is announcing a new €12.2 million funding round, with investments by Generali
FDA Grants Breakthrough Device Designation to Remedee Labs for its groundbreaking endorphin stimulation solution for the management of Fibromyalgia
On World Fibromyalgia Awareness Day (May 12), the French startup Remedee Labs is announcing that the FDA has granted Breakthrough Device Designation to its endorphin
Remedee Labs join Future4care
Remedee Labs, a Grenoble-based startup specializing in integrated chronic pain care centered on its unique endorphin stimulation technology, is joining Future4care, the digital health startup
Gilles Litman, former VP of Digital Health at Sanofi, joins Remedee Labs
French health tech startup Remedee Labs, designer of the first endorphin stimulator for personal use, is hiring Gilles Litman to accelerate growth. As Chief Business
Remedee Labs joins the 2020 MedTech Innovator Accelerator program
MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Their mission is to improve the lives
Remedee Labs starts a study with CEA Clinatec
The challenge of measuring endorphin levels The analgesic effect of millimeter wave (MMW) therapy is due to the release of endogenous opioid – endorphins –
New clinical trial into pain management started by leading French research hospital
The CHU Grenoble research hospital in France has started a clinical trial to evaluate the efficacy of the Remedee Labs endorphin stimulation therapy for peri-surgical
Remedee Labs’ breakthrough endorphin stimulation solution is unveiled
We have developed the first personal endorphin stimulator using advanced millimeter wave technology for electronic pain management. Dubbed the “electronic pain medication”, the solution stimulates
$12 million in funding to accelerate electronic medication breakthrough
Funding to support new endorphin-stimulation pain therapy clinical trials, including arthritic pain, peri-surgical pain relief and migraine Meylan, France, – 14 November 2019 – French startup